Complete Filing Data
ProMIS Neurosciences Inc. reported Stockholders Equity of -$1.26 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ProMIS Neurosciences Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income * | -$39.7M | $2.8M | -$13.2M | -$18.1M | -$9.8M |
| Research And Development Expense | $33.4M | $10.6M | $7.9M | $16.1M | $4.6M |
| Operating Income Loss | -$40.2M | -$16.8M | -$14.3M | -$23.4M | -$8.3M |
| Operating Expenses | $40.2M | $16.8M | $14.3M | $23.4M | $8.3M |
| General And Administrative Expense | $6.8M | $6.2M | $6.4M | $7.3M | $3.7M |
| Nonoperating Income Expense | $448.2K | $19.6M | $1.1M | $5.3M | -$1.5M |
| Comprehensive Income Net Of Tax | $2.8M | -$13.2M | -$18.1M | -$9.9M | |
| Other Nonoperating Income Expense | $442.6K | $626.2K | $384.9K | $115.5K | $12.9K |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$175.8K | -$7.5K | -$137.2K | ||
| Amortization Of Intangible Assets | $20.8K | $5.1K | $5.2K | ||
| Interest Expense | |||||
| Other Nonoperating Income | |||||
| Interest Expense Other | $76.8K | $201.4K | |||
| Interest Expense Debt | $282.1K | $416.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$11.6M | -$10.1M | -$7.3M | $9.3M | -$2.6M | -$3.6M | -$2.4M | -$2.3M | -$5.0M | -$6.0M | -$2.7M | -$2.1M | -$1.2M | -$225.5K |
| Research And Development Expense | $9.8M | $8.7M | $5.5M | $2.6M | $1.6M | $2.1M | $1.1M | $1.0M | $3.5M | $4.6M | $3.2M | $1.9M | $805.4K | $754.3K |
| Operating Income Loss | -$11.8M | -$10.2M | -$7.5M | -$4.4M | -$2.7M | -$3.7M | -$2.5M | -$2.9M | -$5.0M | -$6.1M | -$4.9M | -$3.9M | -$2.1M | -$1.1M |
| Operating Expenses | $11.8M | $10.2M | $7.5M | $4.4M | $2.7M | $3.7M | $2.5M | $2.9M | $5.0M | $6.1M | $4.9M | $3.9M | $2.1M | $1.1M |
| General And Administrative Expense | $2.0M | $1.4M | $2.0M | $1.9M | $1.1M | $1.6M | $1.4M | $1.9M | $1.5M | $1.5M | $1.6M | $2.0M | $1.3M | $351.1K |
| Nonoperating Income Expense | $170.3K | $67.6K | $112.2K | $13.7M | $90.0K | $41.6K | $156.9K | $587.9K | $11.2K | $97.3K | $2.1M | $1.8M | $860.2K | $879.9K |
| Comprehensive Income Net Of Tax | $9.3M | -$2.6M | -$3.6M | -$2.4M | -$2.5M | -$5.0M | -$6.1M | -$2.7M | -$2.0M | -$1.2M | -$317.4K | |||
| Other Nonoperating Income Expense | $31.0K | $132.5K | $113.3K | $30.9K | $52.9K | $35.9K | $16.3K | $10.8K | $4.1K | -$321.00 | ||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$171.5K | -$4.4K | -$131.9K | $1.6K | $47.8K | $42.7K | -$91.8K | |||||||
| Amortization Of Intangible Assets | $1.2K | $1.3K | $1.3K | $1.3K | $1.3K | $1.3K | ||||||||
| Interest Expense | $76.8K | $75.4K | $49.2K | $134.3K | $140.9K | $133.7K | ||||||||
| Other Nonoperating Income | $170.3K | $67.6K | $112.2K | $235.9K | $31.0K | $132.5K | $113.3K | |||||||
| Interest Expense Other | $75.4K | $49.2K | ||||||||||||
| Interest Expense Debt | $134.3K | $147.8K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | -$1.3M | $16.5M | $3.8M | -$1.3M | $5.7M | -$796.7K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.1M | $13.3M | $12.6M | $5.9M | $16.9M | $806.9K |
| Common Stock No Par Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$7.2M | $693.0K | $6.7M | -$11.1M | $16.1M | |
| Short Term Investments | $33.8K | $33.1K | $32.4K | $31.0K | $33.2K | |
| Retained Earnings Accumulated Deficit | -$130.4M | -$90.7M | -$93.5M | -$80.3M | -$62.2M | |
| Prepaid Expense And Other Assets Current | $3.0M | $5.6M | $988.6K | $996.7K | $737.3K | |
| Liabilities Current | $10.4M | $2.2M | $9.3M | $6.4M | $929.1K | |
| Liabilities And Stockholders Equity | $9.2M | $18.9M | $13.6M | $6.9M | $17.7M | |
| Liabilities | $10.4M | $2.4M | $9.9M | $8.3M | $12.1M | |
| Cash And Cash Equivalents At Carrying Value | $6.1M | $13.3M | $12.6M | $5.9M | $16.9M | |
| Assets Current | $9.2M | $18.9M | $13.6M | $6.9M | $17.7M | |
| Assets | $9.2M | $18.9M | $13.6M | $6.9M | $17.7M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$371.2K | -$371.2K | -$371.2K | -$195.4K | -$187.9K | |
| Accrued Liabilities Current | $7.9M | $481.0K | $1.5M | $3.4M | $520.1K | |
| Accounts Payable Current | $2.5M | $1.7M | $7.8M | $3.0M | $409.0K | |
| Apic Share Based Payment Arrangement Re Measurement Of Liability Classified Stock Options | ||||||
| Intangible Assets Net Excluding Goodwill | $20.8K | $27.6K | ||||
| Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent | ||||||
| Property Plant And Equipment Net | $321.00 | $4.7K | ||||
| Gains Losses On Extinguishment Of Debt And Derivative Liability | $1.3M | |||||
| Derivative Liabilities Noncurrent | $2.7M | $5.4M | ||||
| Conversion Of Convertible Debt And Derivative Liability To Series1Convertible Preferred Shares | 5.6M | |||||
| Stock Issued During Period Value Conversion Of Convertible Debt And Derivative Liability | $5.6M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $9.2M | -$382.6K | $9.5M | $7.3M | -$2.3M | $77.1K | $6.8M | -$8.5M | -$6.2M | $729.8K | $6.7M | $3.7M | $7.8M | -$7.1M | -$6.9M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $15.4M | $4.5M | $8.4M | $21.5M | $992.5K | $2.5M | $16.9M | $1.2M | $3.3M | $3.9M | $8.9M | $13.8M | $20.9M | $5.6M | |||
| Common Stock No Par Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$4.9M | -$10.1M | -$2.5M | -$3.2M | |||||||||||||
| Short Term Investments | $33.1K | $33.1K | $33.1K | $32.4K | $32.4K | $32.4K | $31.8K | $31.8K | $31.1K | $30.5K | $32.7K | ||||||
| Retained Earnings Accumulated Deficit | -$119.7M | -$108.2M | -$98.0M | -$90.4M | -$99.7M | -$97.1M | -$89.9M | -$87.5M | -$85.2M | -$73.0M | -$67.0M | ||||||
| Prepaid Expense And Other Assets Current | $6.0M | $5.0M | $5.2M | $2.9M | $384.8K | $1.0M | $957.8K | $224.7K | $1.0M | $1.4M | $1.2M | ||||||
| Liabilities Current | $12.2M | $9.8M | $4.1M | $2.6M | $3.2M | $2.6M | $9.9M | $8.7M | $8.7M | $3.1M | $1.9M | ||||||
| Liabilities And Stockholders Equity | $21.5M | $9.5M | $13.6M | $24.5M | $1.4M | $3.5M | $17.9M | $1.5M | $4.4M | $5.4M | $10.2M | ||||||
| Liabilities | $12.3M | $9.9M | $4.2M | $17.2M | $3.7M | $3.5M | $11.1M | $10.0M | $10.6M | $4.7M | $3.5M | ||||||
| Cash And Cash Equivalents At Carrying Value | $15.4M | $4.5M | $8.4M | $21.5M | $992.5K | $2.5M | $16.9M | $1.2M | $3.3M | $3.9M | $8.9M | ||||||
| Assets Current | $21.5M | $9.5M | $13.6M | $24.5M | $1.4M | $3.5M | $17.9M | $1.5M | $4.4M | $5.4M | $10.2M | ||||||
| Assets | $21.5M | $9.5M | $13.6M | $24.5M | $1.4M | $3.5M | $17.9M | $1.5M | $4.4M | $5.4M | $10.2M | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$371.2K | -$371.2K | -$371.2K | -$371.2K | -$371.2K | -$371.2K | -$371.2K | -$371.2K | -$199.7K | -$270.3K | -$138.4K | ||||||
| Accrued Liabilities Current | $8.0M | $7.0M | $2.9M | $1.1M | $1.2M | $1.2M | $1.4M | $775.9K | $1.7M | $1.3M | $986.0K | ||||||
| Accounts Payable Current | $4.2M | $2.8M | $1.2M | $1.6M | $2.0M | $1.4M | $8.4M | $8.0M | $7.0M | $1.8M | $888.0K | ||||||
| Apic Share Based Payment Arrangement Re Measurement Of Liability Classified Stock Options | $8.2K | $50.7K | $86.2K | $125.4K | $251.5K | -$295.0K | $443.5K | ||||||||||
| Intangible Assets Net Excluding Goodwill | $18.0K | $18.8K | $19.7K | $21.7K | $24.6K | ||||||||||||
| Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent | $54.2K | $62.4K | $113.1K | $199.3K | $340.1K | $465.5K | $717.0K | $422.0K | $992.3K | ||||||||
| Property Plant And Equipment Net | $788.00 | $2.8K | |||||||||||||||
| Gains Losses On Extinguishment Of Debt And Derivative Liability | $1.3M | ||||||||||||||||
| Derivative Liabilities Noncurrent | |||||||||||||||||
| Conversion Of Convertible Debt And Derivative Liability To Series1Convertible Preferred Shares | |||||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Debt And Derivative Liability | $5.6M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $857.6K | $825.8K | $271.5K | $487.6K | $515.6K |
| Net Cash Provided By Used In Operating Activities | -$28.1M | -$27.2M | -$10.8M | -$17.0M | -$9.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$2.6M | $4.6M | $187.3K | $318.7K | $600.6K |
| Increase Decrease In Accrued Liabilities | $7.4M | -$1.0M | -$1.8M | $3.0M | $471.5K |
| Increase Decrease In Accounts Payable | $806.0K | -$6.1M | $5.0M | $2.7M | -$31.7K |
| Net Cash Provided By Used In Financing Activities | $20.9M | $27.9M | $17.7M | $6.5M | $25.5M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | -$181.4K | -$526.9K | -$175.0K | ||
| Net Cash Provided By Used In Investing Activities | -$702.00 | -$693.00 | -$1.3K | -$2.0K | $94.6K |
| Proceeds From Issuance Of Common Stock | $708.5K | $190.3K | $5.0M | $15.9M | |
| Payments To Acquire Property Plant And Equipment | $2.0K | $6.0K | |||
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | $33.1K | $32.4K | $31.0K | $31.0K | $33.1K |
| Payments To Acquire Short Term Investments | $33.8K | $33.1K | $32.4K | $31.0K | $33.1K |
| Proceeds From Warrant Exercises | $3.1K | $28.0K | $3.6K | ||
| Apic Share Based Payment Arrangement Equity Classified Stock Options To Share Based Compensation Liability Due To Change In Functional Currency | $1.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q3 2023 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|---|
| Share Based Compensation | $245.3K | $63.6K | $132.5K | $124.9K | |
| Net Cash Provided By Used In Operating Activities | -$4.9M | -$10.3M | -$2.6M | -$3.4M | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$337.9K | $30.3K | $46.0K | -$122.9K | |
| Increase Decrease In Accrued Liabilities | $2.4M | -$264.2K | -$1.7M | $215.2K | |
| Increase Decrease In Accounts Payable | -$537.3K | -$6.4M | $4.0M | $226.9K | |
| Net Cash Provided By Used In Financing Activities | $190.3K | ||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $17.7K | $179.1K | |||
| Net Cash Provided By Used In Investing Activities | -$2.1K | ||||
| Proceeds From Issuance Of Common Stock | $190.3K | ||||
| Payments To Acquire Property Plant And Equipment | $2.1K | ||||
| Proceeds From Maturities Prepayments And Calls Of Shortterm Investments | |||||
| Payments To Acquire Short Term Investments | |||||
| Proceeds From Warrant Exercises | |||||
| Apic Share Based Payment Arrangement Equity Classified Stock Options To Share Based Compensation Liability Due To Change In Functional Currency | -$1.4M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 1.8M | 1.0M | 12.3M | 7.5M | 5.8M |
| Earnings Per Share Basic | $-22.61 | $2.68 | $-1.07 | $-2.41 | $-1.69 |
| Weighted Average Number Of Diluted Shares Outstanding | 1.8M | 1.1M | 12.3M | 7.5M | 5.8M |
| Earnings Per Share Diluted | $-22.61 | $2.63 | $-1.07 | $-2.41 | $-1.69 |
| Common Stock Shares Outstanding | 2.2M | 1.3M | 18.9M | 8.6M | 7.2M |
| Common Stock Shares Issued | 2.2M | 1.3M | 18.9M | 8.6M | 7.2M |
| Preferred Stock Shares Outstanding | 0.00 | ||||
| Preferred Stock Shares Issued | 0.00 | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | ||||
| Preferred Stock Shares Authorized | 70.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 48.8M | 34.9M | 34.9M | 30.0M | 19.8M | 19.5M | 12.4M | 8.6M | 8.6M | 7.2M | 7.2M | 7.2M | 5.9M | 5.1M | ||
| Earnings Per Share Basic | $-0.24 | $-0.29 | $-0.21 | $0.31 | $-0.13 | $-0.19 | $-0.19 | $-0.27 | $-0.58 | $-0.83 | $-0.38 | $-0.29 | $-0.20 | $-0.06 | ||
| Weighted Average Number Of Diluted Shares Outstanding | 48.8M | 34.9M | 34.9M | 30.1M | 19.8M | 19.5M | 12.4M | 8.6M | 8.6M | 7.2M | 7.2M | 7.2M | 5.9M | 5.1M | ||
| Earnings Per Share Diluted | $-0.24 | $-0.29 | $-0.21 | $0.31 | $-0.13 | $-0.19 | $-0.19 | $-0.27 | $-0.58 | $-0.83 | $-0.38 | $-0.29 | $-0.20 | $-0.06 | ||
| Common Stock Shares Outstanding | 53.8M | 32.7M | 32.7M | 32.7M | 19.0M | 19.0M | 18.5M | 8.6M | 8.6M | 7.2M | 7.2M | |||||
| Common Stock Shares Issued | 53.8M | 32.7M | 32.7M | 32.7M | 19.0M | 19.0M | 18.5M | 8.6M | 8.6M | 7.2M | 7.2M | |||||
| Preferred Stock Shares Outstanding | 0.00 | 1.2M | 1.2M | 1.2M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | ||||||
| Preferred Stock Shares Issued | 0.00 | 1.2M | 1.2M | 1.2M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Preferred Stock Shares Authorized | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M | 70.0M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $857.6K | $825.8K | $271.5K | $487.6K | $515.6K |
| Gain Loss From Change In Fair Value Of Financial Instruments | $5.6K | $22.6M | $866.7K | $4.2M | -$1.1M |
| Additional Paid In Capital | $129.5M | $107.5M | $97.6M | $79.1M | $68.0M |
| Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares | 5.6K | 94.2K | 1.9M | 1.9M | |
| Depreciation | $321.00 | $6.1K | $40.6K | ||
| Foreign Currency Transaction Gain Loss Before Tax | $1.8K | -$305.4K | -$85.1K | ||
| Fair Value Adjustment Of Warrants | -$866.7K | -$1.6M | -$840.6K | ||
| Unrealized Gain Loss On Derivatives | $5.6K | $22.6M | $866.7K | $2.6M | -$1.9M |
| Stock Issued During Period Value New Issues | $190.3K | $17.7M | $5.0M | $15.9M | |
| Amortization Of Financing Costs And Discounts | $241.9K | $366.0K | |||
| Stock Issued During Period Value Warrants Exercised | $3.1K | $28.0K | $3.6K | ||
| Adjustments To Additional Paid In Capital Warrant Issued | $697.7K | $8.7M | $1.3M | ||
| Other Interest Paid | $201.4K | ||||
| Interest Paid Net | $76.8K | $201.4K | $87.1K | ||
| Loss On Sale Of Common Shares And Warrants | 3.5M | ||||
| Issuance Of Compensation Warrants In Consideration Of Issuance Costs | $466.7K | $317.0K | $957.9K | ||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $2.7M | $977.6K | $1.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $197.1K | $212.0K | $245.3K | $121.0K | $18.0K | $63.6K | $134.2K | $132.5K | $108.6K | $115.4K | $124.9K | $189.6K | $129.2K | |
| Gain Loss From Change In Fair Value Of Financial Instruments | $17.0M | $59.1K | -$14.1K | $119.0K | $606.2K | -$41.7K | $61.4K | $930.2K | $2.0M | $997.1K | $1.0M | |||
| Additional Paid In Capital | $129.3M | $108.1M | $107.9M | $98.1M | $97.8M | $97.5M | $97.0M | $79.4M | $79.2M | $74.0M | $73.9M | |||
| Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares | 5.6K | 5.6K | 5.6K | 14.3M | 49.2K | 108.3K | 277.4K | 1.3M | 1.9M | 1.6M | 1.6M | |||
| Depreciation | $322.00 | $1.9K | $2.1K | $1.8K | $10.9K | $10.8K | ||||||||
| Foreign Currency Transaction Gain Loss Before Tax | $5.0K | $114.7K | ||||||||||||
| Fair Value Adjustment Of Warrants | $14.1K | $41.7K | -$244.6K | |||||||||||
| Unrealized Gain Loss On Derivatives | $1.7M | |||||||||||||
| Stock Issued During Period Value New Issues | $708.5K | $190.3K | $17.7M | $15.9M | ||||||||||
| Amortization Of Financing Costs And Discounts | $130.6K | |||||||||||||
| Stock Issued During Period Value Warrants Exercised | $3.1K | $28.0K | ||||||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | $697.7K | $1.3M | ||||||||||||
| Other Interest Paid | $76.8K | |||||||||||||
| Interest Paid Net | $70.0K | |||||||||||||
| Loss On Sale Of Common Shares And Warrants | 3.5M | |||||||||||||
| Issuance Of Compensation Warrants In Consideration Of Issuance Costs | ||||||||||||||
| Adjustments To Additional Paid In Capital Stock Issued Issuance Costs | $2.7M | $1.7M |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 10, 2026.